Medicare won’t cover anti-obesity GLP-1 drugs as Biden admin proposed
In November last year, the Biden administration proposed a new rule that would allow drugs like Wegovy and Zepbound to be ...
FingerLakes1.com6h
Medicare Will Not Cover Anti-Obesity Drugs Like Wegovy and Zepbound, CMS Says
CMS ends Biden-era proposal to expand Medicare coverage of anti-obesity drugs. Seniors continue paying out of pocket for ...
Axios on MSN1d
Trump admin won't let Medicare cover anti-obesity drugs
The Trump administration on Friday scrapped a Biden administration proposal to have Medicare cover anti-obesity drugs, ...
Trump pulls back Biden’s plan to cover weight loss drugs
Health and Human Services Secretary Robert F. Kennedy Jr. has been critical of the drugs, instead placing a focus on ...
Trump drops Medicare obesity drug proposal
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump officials reject Medicare coverage ...
AFN2d
Anti-obesity medications offer an opportunity to cut food waste—and costs
The rise of GLP-1 drugs like Ozempic are changing consumer food waste patterns both at home and in restaurant settings.
Fierce Healthcare1d
Medicare Advantage final rule excludes anti-obesity drug coverage under Medicare, Medicaid
The Centers for Medicare and Medicaid Services (CMS) finalized a Medicare Advantage (MA) rule proposed by the Biden ...
News Medical on MSN6d
Expanding access to anti-obesity medications delivers 13% return on investment for society
A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...
Medicare and Medicaid will not cover weight loss drugs, Trump administration decides
The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, the Centers for Medicare and Medicaid Services said in a filing published ...